OVARIAN SEROUS ADENOCARCINOMA
Clinical trials for OVARIAN SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Mesothelin-Positive tumors
Disease control TerminatedThis trial tests a new cell therapy called TC-510 for people with advanced cancers that have a protein called mesothelin on their surface, including mesothelioma, ovarian cancer, and pancreatic cancer. TC-510 uses a patient's own immune cells, which are genetically modified to be…
Matched conditions: OVARIAN SEROUS ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: TCR2 Therapeutics • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Measles virus takes on ovarian cancer in early trial
Disease control TerminatedThis phase 2 trial tested a genetically modified measles virus (MV-NIS) against standard chemotherapy in 17 women with ovarian, fallopian, or peritoneal cancer that no longer responded to platinum drugs. The virus was designed to infect and kill cancer cells while leaving healthy…
Matched conditions: OVARIAN SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC